Xeris Biopharma Holdings
XERS
XERS
53 hedge funds and large institutions have $176M invested in Xeris Biopharma Holdings in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3.78% more ownership
Funds ownership: 62.6% → 66.37% (+3.8%)
9% less capital invested
Capital invested by funds: $193M → $176M (-$16.8M)
Holders
53
Holding in Top 10
–
Calls
$9K
Puts
$3K
Top Buyers
| 1 | +$6.57M | |
| 2 | +$2.44M | |
| 3 | +$918K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$741K |
| 5 |
State Street
Boston,
Massachusetts
|
+$667K |
Top Sellers
| 1 | -$2.24M | |
| 2 | -$700K | |
| 3 | -$492K | |
| 4 |
Renaissance Technologies
New York
|
-$225K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$123K |